These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3548190)

  • 1. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
    Whiteside TL; Dekker A
    Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
    Pinto MM; Bernstein LH; Rudolph RA; Brogan DA; Rosman M
    Arch Pathol Lab Med; 1992 Jun; 116(6):626-31. PubMed ID: 1616424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen assay in fine needle aspirate of pancreas: a diagnostic adjunct to cytology.
    Pinto MM; Levine RH
    Am J Gastroenterol; 1992 Apr; 87(4):530-3. PubMed ID: 1553944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen content in fine needle aspirates of the lung. A diagnostic adjunct to cytology.
    Pinto MM; Ha DJ
    Acta Cytol; 1992; 36(3):277-82. PubMed ID: 1580109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
    Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
    Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
    Orell SR; Dowling KD
    Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic examination and carcinoembryonic antigen assay of fine needle aspirates of bone tumors.
    D'Cunha S; Pinto MM
    Acta Cytol; 1994; 38(4):543-6. PubMed ID: 8042420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
    Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
    Delahaye M; Hoogsteden HC; Van der Kwast TH
    J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
    Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
    Gulyás M; Elek G; Molnár M; Szollár L
    Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions].
    Jiang XF; Zhu YJ; Zhao WL; Ma X; Lo WC
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):430-1. PubMed ID: 3582109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
    Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
    Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of lysozyme, alpha 1-anti-chymotrypsin, tissue polypeptide antigen, keratin and carcinoembryonic antigen in effusion sediments.
    Permanetter W; Wiesinger H
    Acta Cytol; 1987; 31(2):104-12. PubMed ID: 2435101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.